Clinical Trials
129 trialsNCT04181463 2026-05-27
Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07606443 2026-05-26
COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
Stanford University
Phase NA Not yet recruiting
NCT07489820 2026-05-22
AAPICO
Centre Hospitalier Departemental Vendee
Phase NA Not yet recruiting
NCT07600749 2026-05-22
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
Merck Sharp & Dohme LLC
Phase 1 Not yet recruiting
NCT07596745 2026-05-19
Telerehabilitation-Based Dance Therapy in Pediatric Cancer
Akdeniz University
Phase NA Not yet recruiting
NCT07594431 2026-05-18
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
Stanford University
Phase 2 Not yet recruiting
NCT07583654 2026-05-13
Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
West China Hospital
Phase 1 Not yet recruiting
NCT07583979 2026-05-13
EAST-ALIGN
National Cancer Centre, Singapore
Phase 3 Not yet recruiting
NCT07562815 2026-05-11
Safety and Tolerability of NCP-IL-22BP mRNA in Advanced Solid Tumors
West China Hospital
Phase 1 Not yet recruiting
NCT07541365 2026-05-08
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
Case Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT07572318 2026-05-07
HELIOS
Central Hospital, Nancy, France
Phase NA Not yet recruiting
NCT06979310 2026-05-06
The Comparative Effectiveness Evaluation of the Impact of Digital Education
Duke University
Phase NA Not yet recruiting
NCT07563829 2026-05-04
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
NextPoint Therapeutics, Inc.
Phase 1 Not yet recruiting
NCT07562581 2026-05-01
A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2 Not yet recruiting
NCT07041788 2026-04-30
Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
Second Affiliated Hospital of Nanchang University
Phase 2 Not yet recruiting
NCT07557043 2026-04-29
BALanSE
University of Southern Denmark
Phase NA Not yet recruiting
NCT07165912 2026-04-28
Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
University of Salamanca
Phase NA Not yet recruiting
NCT07232043 2026-04-28
ACTIVATE
Dana-Farber Cancer Institute
Phase NA Not yet recruiting
NCT07550192 2026-04-24
Oncology Acute Care Follow-up Intervention Study
University of Texas Southwestern Medical Center
Phase NA Not yet recruiting
NCT07550478 2026-04-24
Impact of Pharmacist-Led Intervention on Adult Oncology Outpatients
Badr University
Phase NA Not yet recruiting
NCT07535918 2026-04-22
Using e-Technologies to Maximize Physical Activity After Cancer Treatment
University of Florida
Phase NA Not yet recruiting
NCT07485322 2026-04-21
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Inova Health Care Services
Phase NA Not yet recruiting
NCT07540650 2026-04-20
pRevenT
Institute of Oncology Ljubljana
Phase 2 Not yet recruiting
NCT01481532 2026-04-15
Open Label Clinical Trial of Intravenous Crotoxin Part 3
Celtic Biotech Ltd
Phase 1 Not yet recruiting
NCT07515274 2026-04-13
EQUICAP
Centre Leon Berard
Phase NA Not yet recruiting
NCT07524140 2026-04-13
Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.
Eilean Therapeutics
Phase 1 Not yet recruiting
NCT07518797 2026-04-09
ASPIRE AI
Rabin Medical Center
Phase NA Not yet recruiting
NCT07346209 2026-04-08
STRIPe
University of California, San Diego
Phase 2 Not yet recruiting
NCT07511023 2026-04-06
Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07498725 2026-03-27
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
Phase 1/2 Not yet recruiting
NCT06744712 2026-03-25
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
Wake Forest University Health Sciences
Phase NA Not yet recruiting
NCT07487805 2026-03-23
ICONIC
University of Florida
Phase 2 Not yet recruiting
NCT07476443 2026-03-17
VitC-CoQ10
Ain Shams University
Phase 2/3 Not yet recruiting
NCT07454031 2026-03-13
Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma
Peking University
Phase 1 Not yet recruiting
NCT07453706 2026-03-09
The Application of Sentire Surgical System Plus Patient Side Single Arm in Robotic Colorectal Surgery
Chinese University of Hong Kong
Phase NA Not yet recruiting
NCT07454499 2026-03-06
Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
Abramson Cancer Center at Penn Medicine
Phase NA Not yet recruiting
NCT07450703 2026-03-05
The Effect of the Health Belief Model-Based Education Given to Mothers of Children Aged 9-15 on HPV Knowledge Level and Child Vaccination
University of Gaziantep
Phase NA Not yet recruiting
NCT07354100 2026-03-04
(BLOOM)
University of Chicago
Phase 1/2 Not yet recruiting
NCT07444645 2026-03-03
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT07105046 2026-03-02
Facilitators and Barriers to Cancer Treatment Among Texas Residents
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT07431073 2026-02-24
METAREM
UNICANCER
Phase 2 Not yet recruiting
NCT07408999 2026-02-13
MIRO-2
University Hospital, Lille
Phase NA Not yet recruiting
NCT07404332 2026-02-11
5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
University of Iowa
Phase 1 Not yet recruiting
NCT06441773 2026-02-10
REHABIM
University Hospital, Brest
Phase NA Not yet recruiting
NCT07390019 2026-02-05
FamCASP
Malmö University
Phase NA Not yet recruiting
NCT07390643 2026-02-05
DISCOVERY
Dana-Farber Cancer Institute
Phase NA Not yet recruiting
NCT06605196 2026-02-04
AHD
Washington University School of Medicine
Phase NA Not yet recruiting
NCT07385703 2026-02-04
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Not yet recruiting
NCT07378761 2026-01-30
CHILURSO
University Hospital, Montpellier
Phase 2 Not yet recruiting
NCT07372508 2026-01-28
GALACTIC-1
NHS Greater Glasgow and Clyde
Phase NA Not yet recruiting